Fingerprint
Dive into the research topics of 'Paclitaxel as first- or second-line treatment for HIV-negative Kaposi’s sarcoma: a retrospective study of 58 patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Paclitaxel as first- or second-line treatment for HIV-negative Kaposi’s sarcoma: a retrospective study of 58 patients
Athanasia Tourlaki, Francesca Germiniasi, Luisa Carlotta Rossi, Stefano Veraldi, Lucia Brambilla
Research output: Contribution to journal › Article › peer-review